Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochim Biophys Acta. 2007 Jan;1772(1):21-5. Epub 2006 Oct 6.

Preliminary observation of elevated levels of nanocrystalline iron oxide in the basal ganglia of neuroferritinopathy patients.

Author information

1
Institute of Science and Technology in Medicine, Keele University, Stoke on Trent, and Institute for Aging and Health, Newcastle General Hospital, Newcastle upon Tyne, UK. dimitri@biomagnetism.co.uk

Abstract

Magnetometry analysis of brain tissue sub-samples from two neuroferritinopathy patients provides a preliminary indication that the amount of magnetic iron compounds associated with this rare disease is significantly larger than in age/sex-matched controls. The primary iron compounds contributing to the remnant magnetization of the tissue above 50 K and at body temperature are both blocked and superparamagnetic (SPM) biogenic magnetite (Fe3O4) and/or maghemite (gamma-Fe2O3). The concentration of SPM magnetite is significant and appears to be proportional to the concentration of ferritin, which varies with progression of the disease. The mutated ferritin protein appears to be responsible for the presence of iron oxide nano-particules, which in turn could be responsible for extensive damage in the brain.

PMID:
17097860
PMCID:
PMC1993816
DOI:
10.1016/j.bbadis.2006.09.011
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center